Anabolic steroid-associated liver injury
- 1 January 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Liver Disease
- Vol. 23 (1) , e0196
Abstract
ExportKeywords
This publication has 14 references indexed in Scilit:
- Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in AustraliaAlimentary Pharmacology & Therapeutics, 2024
- Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI NetworkClinical Gastroenterology and Hepatology, 2022
- Versatility of Anabolic Androgenic Steroid–Induced HepatotoxicityJournal of Clinical and Experimental Hepatology, 2022
- Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factorsAlimentary Pharmacology & Therapeutics, 2019
- Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration WarningsJAMA Network Open, 2018
- History and epidemiology of anabolic androgens in athletes and non-athletesMolecular and Cellular Endocrinology, 2018
- Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroidsAlimentary Pharmacology & Therapeutics, 2014
- Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations?Liver International, 2013
- Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activitiesSteroids, 2009
- A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroidsClinical Therapeutics, 2001